aluates Reports

$ 0.0

Automative

Global Generic Injection Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-37X5172

Global Generic Injection Market Insights Forecast to 2028

BUY CHAPTERS

Global Generic Injection Market Research Report 2025

Code: QYRE-Auto-37X5172

Report

July 2025

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Fresenius

Viatris

Pfizer Inc

Teva Pharmaceuticals

Hikma Pharmaceuticals

Novartis

Amneal Pharmaceuticals

Gland Pharma

Allergan plc

Kelun Pharmaceutical

Jiangsu HRS

Qilu Pharmaceutical

Chiatai Tianqing

Hainan Poly Pharm

Yangzijiang Pharmaceutical Industry

Shijiazhuang Pharma Group

Generic Injection Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Generic Injection Market

The global market for Generic Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Generic Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injection.

The Generic Injection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Generic Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Generic Injection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Generic Injection Market Report

Report Metric	Details
Report Name	Generic Injection Market
CAGR	5%
Segment by Type	Liquid Injection Powder for Injection
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Fresenius, Viatris, Pfizer, Teva Pharmaceuticals, Hikma Pharmaceuticals, Novartis, Amneal Pharmaceuticals, Gland Pharma, Allergan, Kelun Pharmaceutical, Jiangsu HRS, Qilu Pharmaceutical, Chiatai Tianqing, Hainan Poly Pharm, Yangzijiang Pharmaceutical Industry, Shijiazhuang Pharma Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Generic Injection Market report?

Ans: The main players in the Generic Injection Market are Sanofi, Fresenius, Viatris, Pfizer, Teva Pharmaceuticals, Hikma Pharmaceuticals, Novartis, Amneal Pharmaceuticals, Gland Pharma, Allergan, Kelun Pharmaceutical, Jiangsu HRS, Qilu Pharmaceutical, Chiatai Tianqing, Hainan Poly Pharm, Yangzijiang Pharmaceutical Industry, Shijiazhuang Pharma Group

What are the Application segmentation covered in the Generic Injection Market report?

Ans: The Applications covered in the Generic Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Generic Injection Market report?

Ans: The Types covered in the Generic Injection Market report are Liquid Injection, Powder for Injection

Recommended Reports

Injectable Pharmaceuticals

Diagnostic Solutions

Therapeutics & Disease

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Generic Injection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Liquid Injection

1.2.3 Powder for Injection

1.3 Market by Application

1.3.1 Global Generic Injection Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Generic Injection Market Perspective (2020-2031)

2.2 Global Generic Injection Growth Trends by Region

2.2.1 Global Generic Injection Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Generic Injection Historic Market Size by Region (2020-2025)

2.2.3 Generic Injection Forecasted Market Size by Region (2026-2031)

2.3 Generic Injection Market Dynamics

2.3.1 Generic Injection Industry Trends

2.3.2 Generic Injection Market Drivers

2.3.3 Generic Injection Market Challenges

2.3.4 Generic Injection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Generic Injection Players by Revenue

3.1.1 Global Top Generic Injection Players by Revenue (2020-2025)

3.1.2 Global Generic Injection Revenue Market Share by Players (2020-2025)

3.2 Global Generic Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Generic Injection Revenue

3.4 Global Generic Injection Market Concentration Ratio

3.4.1 Global Generic Injection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Generic Injection Revenue in 2024

3.5 Global Key Players of Generic Injection Head office and Area Served

3.6 Global Key Players of Generic Injection, Product and Application

3.7 Global Key Players of Generic Injection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Generic Injection Breakdown Data by Type

4.1 Global Generic Injection Historic Market Size by Type (2020-2025)

4.2 Global Generic Injection Forecasted Market Size by Type (2026-2031)

5 Generic Injection Breakdown Data by Application

5.1 Global Generic Injection Historic Market Size by Application (2020-2025)

5.2 Global Generic Injection Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Generic Injection Market Size (2020-2031)

6.2 North America Generic Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Generic Injection Market Size by Country (2020-2025)

6.4 North America Generic Injection Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Generic Injection Market Size (2020-2031)

7.2 Europe Generic Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Generic Injection Market Size by Country (2020-2025)

7.4 Europe Generic Injection Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Generic Injection Market Size (2020-2031)

8.2 Asia-Pacific Generic Injection Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Generic Injection Market Size by Region (2020-2025)

8.4 Asia-Pacific Generic Injection Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Generic Injection Market Size (2020-2031)

9.2 Latin America Generic Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Generic Injection Market Size by Country (2020-2025)

9.4 Latin America Generic Injection Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Generic Injection Market Size (2020-2031)

10.2 Middle East & Africa Generic Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Generic Injection Market Size by Country (2020-2025)

10.4 Middle East & Africa Generic Injection Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Generic Injection Introduction

11.1.4 Sanofi Revenue in Generic Injection Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Fresenius

11.2.1 Fresenius Company Details

11.2.2 Fresenius Business Overview

11.2.3 Fresenius Generic Injection Introduction

11.2.4 Fresenius Revenue in Generic Injection Business (2020-2025)

11.2.5 Fresenius Recent Development

11.3 Viatris

11.3.1 Viatris Company Details

11.3.2 Viatris Business Overview

11.3.3 Viatris Generic Injection Introduction

11.3.4 Viatris Revenue in Generic Injection Business (2020-2025)

11.3.5 Viatris Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Generic Injection Introduction

11.4.4 Pfizer Revenue in Generic Injection Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Teva Pharmaceuticals

11.5.1 Teva Pharmaceuticals Company Details

11.5.2 Teva Pharmaceuticals Business Overview

11.5.3 Teva Pharmaceuticals Generic Injection Introduction

11.5.4 Teva Pharmaceuticals Revenue in Generic Injection Business (2020-2025)

11.5.5 Teva Pharmaceuticals Recent Development

11.6 Hikma Pharmaceuticals

11.6.1 Hikma Pharmaceuticals Company Details

11.6.2 Hikma Pharmaceuticals Business Overview

11.6.3 Hikma Pharmaceuticals Generic Injection Introduction

11.6.4 Hikma Pharmaceuticals Revenue in Generic Injection Business (2020-2025)

11.6.5 Hikma Pharmaceuticals Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Generic Injection Introduction

11.7.4 Novartis Revenue in Generic Injection Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 Amneal Pharmaceuticals

11.8.1 Amneal Pharmaceuticals Company Details

11.8.2 Amneal Pharmaceuticals Business Overview

11.8.3 Amneal Pharmaceuticals Generic Injection Introduction

11.8.4 Amneal Pharmaceuticals Revenue in Generic Injection Business (2020-2025)

11.8.5 Amneal Pharmaceuticals Recent Development

11.9 Gland Pharma

11.9.1 Gland Pharma Company Details

11.9.2 Gland Pharma Business Overview

11.9.3 Gland Pharma Generic Injection Introduction

11.9.4 Gland Pharma Revenue in Generic Injection Business (2020-2025)

11.9.5 Gland Pharma Recent Development

11.10 Allergan

11.10.1 Allergan Company Details

11.10.2 Allergan Business Overview

11.10.3 Allergan Generic Injection Introduction

11.10.4 Allergan Revenue in Generic Injection Business (2020-2025)

11.10.5 Allergan Recent Development

11.11 Kelun Pharmaceutical

11.11.1 Kelun Pharmaceutical Company Details

11.11.2 Kelun Pharmaceutical Business Overview

11.11.3 Kelun Pharmaceutical Generic Injection Introduction

11.11.4 Kelun Pharmaceutical Revenue in Generic Injection Business (2020-2025)

11.11.5 Kelun Pharmaceutical Recent Development

11.12 Jiangsu HRS

11.12.1 Jiangsu HRS Company Details

11.12.2 Jiangsu HRS Business Overview

11.12.3 Jiangsu HRS Generic Injection Introduction

11.12.4 Jiangsu HRS Revenue in Generic Injection Business (2020-2025)

11.12.5 Jiangsu HRS Recent Development

11.13 Qilu Pharmaceutical

11.13.1 Qilu Pharmaceutical Company Details

11.13.2 Qilu Pharmaceutical Business Overview

11.13.3 Qilu Pharmaceutical Generic Injection Introduction

11.13.4 Qilu Pharmaceutical Revenue in Generic Injection Business (2020-2025)

11.13.5 Qilu Pharmaceutical Recent Development

11.14 Chiatai Tianqing

11.14.1 Chiatai Tianqing Company Details

11.14.2 Chiatai Tianqing Business Overview

11.14.3 Chiatai Tianqing Generic Injection Introduction

11.14.4 Chiatai Tianqing Revenue in Generic Injection Business (2020-2025)

11.14.5 Chiatai Tianqing Recent Development

11.15 Hainan Poly Pharm

11.15.1 Hainan Poly Pharm Company Details

11.15.2 Hainan Poly Pharm Business Overview

11.15.3 Hainan Poly Pharm Generic Injection Introduction

11.15.4 Hainan Poly Pharm Revenue in Generic Injection Business (2020-2025)

11.15.5 Hainan Poly Pharm Recent Development

11.16 Yangzijiang Pharmaceutical Industry

11.16.1 Yangzijiang Pharmaceutical Industry Company Details

11.16.2 Yangzijiang Pharmaceutical Industry Business Overview

11.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Introduction

11.16.4 Yangzijiang Pharmaceutical Industry Revenue in Generic Injection Business (2020-2025)

11.16.5 Yangzijiang Pharmaceutical Industry Recent Development

11.17 Shijiazhuang Pharma Group

11.17.1 Shijiazhuang Pharma Group Company Details

11.17.2 Shijiazhuang Pharma Group Business Overview

11.17.3 Shijiazhuang Pharma Group Generic Injection Introduction

11.17.4 Shijiazhuang Pharma Group Revenue in Generic Injection Business (2020-2025)

11.17.5 Shijiazhuang Pharma Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Fresenius

Viatris

Pfizer Inc

Teva Pharmaceuticals

Hikma Pharmaceuticals

Novartis

Amneal Pharmaceuticals

Gland Pharma

Allergan plc

Kelun Pharmaceutical

Jiangsu HRS

Qilu Pharmaceutical

Chiatai Tianqing

Hainan Poly Pharm

Yangzijiang Pharmaceutical Industry

Shijiazhuang Pharma Group

List of Tables

Table 1. Global Generic Injection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Liquid Injection

Table 3. Key Players of Powder for Injection

Table 4. Global Generic Injection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Generic Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Generic Injection Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Generic Injection Market Share by Region (2020-2025)

Table 8. Global Generic Injection Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Generic Injection Market Share by Region (2026-2031)

Table 10. Generic Injection Market Trends

Table 11. Generic Injection Market Drivers

Table 12. Generic Injection Market Challenges

Table 13. Generic Injection Market Restraints

Table 14. Global Generic Injection Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Generic Injection Market Share by Players (2020-2025)

Table 16. Global Top Generic Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injection as of 2024)

Table 17. Ranking of Global Top Generic Injection Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Generic Injection Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Generic Injection, Headquarters and Area Served

Table 20. Global Key Players of Generic Injection, Product and Application

Table 21. Global Key Players of Generic Injection, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Generic Injection Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Generic Injection Revenue Market Share by Type (2020-2025)

Table 25. Global Generic Injection Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Generic Injection Revenue Market Share by Type (2026-2031)

Table 27. Global Generic Injection Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Generic Injection Revenue Market Share by Application (2020-2025)

Table 29. Global Generic Injection Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Generic Injection Revenue Market Share by Application (2026-2031)

Table 31. North America Generic Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Generic Injection Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Generic Injection Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Generic Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Generic Injection Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Generic Injection Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Generic Injection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Generic Injection Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Generic Injection Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Generic Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Generic Injection Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Generic Injection Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Generic Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Generic Injection Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Generic Injection Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sanofi Company Details

Table 47. Sanofi Business Overview

Table 48. Sanofi Generic Injection Product

Table 49. Sanofi Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 50. Sanofi Recent Development

Table 51. Fresenius Company Details

Table 52. Fresenius Business Overview

Table 53. Fresenius Generic Injection Product

Table 54. Fresenius Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 55. Fresenius Recent Development

Table 56. Viatris Company Details

Table 57. Viatris Business Overview

Table 58. Viatris Generic Injection Product

Table 59. Viatris Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 60. Viatris Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer Generic Injection Product

Table 64. Pfizer Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Teva Pharmaceuticals Company Details

Table 67. Teva Pharmaceuticals Business Overview

Table 68. Teva Pharmaceuticals Generic Injection Product

Table 69. Teva Pharmaceuticals Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 70. Teva Pharmaceuticals Recent Development

Table 71. Hikma Pharmaceuticals Company Details

Table 72. Hikma Pharmaceuticals Business Overview

Table 73. Hikma Pharmaceuticals Generic Injection Product

Table 74. Hikma Pharmaceuticals Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 75. Hikma Pharmaceuticals Recent Development

Table 76. Novartis Company Details

Table 77. Novartis Business Overview

Table 78. Novartis Generic Injection Product

Table 79. Novartis Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 80. Novartis Recent Development

Table 81. Amneal Pharmaceuticals Company Details

Table 82. Amneal Pharmaceuticals Business Overview

Table 83. Amneal Pharmaceuticals Generic Injection Product

Table 84. Amneal Pharmaceuticals Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 85. Amneal Pharmaceuticals Recent Development

Table 86. Gland Pharma Company Details

Table 87. Gland Pharma Business Overview

Table 88. Gland Pharma Generic Injection Product

Table 89. Gland Pharma Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 90. Gland Pharma Recent Development

Table 91. Allergan Company Details

Table 92. Allergan Business Overview

Table 93. Allergan Generic Injection Product

Table 94. Allergan Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 95. Allergan Recent Development

Table 96. Kelun Pharmaceutical Company Details

Table 97. Kelun Pharmaceutical Business Overview

Table 98. Kelun Pharmaceutical Generic Injection Product

Table 99. Kelun Pharmaceutical Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 100. Kelun Pharmaceutical Recent Development

Table 101. Jiangsu HRS Company Details

Table 102. Jiangsu HRS Business Overview

Table 103. Jiangsu HRS Generic Injection Product

Table 104. Jiangsu HRS Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 105. Jiangsu HRS Recent Development

Table 106. Qilu Pharmaceutical Company Details

Table 107. Qilu Pharmaceutical Business Overview

Table 108. Qilu Pharmaceutical Generic Injection Product

Table 109. Qilu Pharmaceutical Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 110. Qilu Pharmaceutical Recent Development

Table 111. Chiatai Tianqing Company Details

Table 112. Chiatai Tianqing Business Overview

Table 113. Chiatai Tianqing Generic Injection Product

Table 114. Chiatai Tianqing Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 115. Chiatai Tianqing Recent Development

Table 116. Hainan Poly Pharm Company Details

Table 117. Hainan Poly Pharm Business Overview

Table 118. Hainan Poly Pharm Generic Injection Product

Table 119. Hainan Poly Pharm Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 120. Hainan Poly Pharm Recent Development

Table 121. Yangzijiang Pharmaceutical Industry Company Details

Table 122. Yangzijiang Pharmaceutical Industry Business Overview

Table 123. Yangzijiang Pharmaceutical Industry Generic Injection Product

Table 124. Yangzijiang Pharmaceutical Industry Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 125. Yangzijiang Pharmaceutical Industry Recent Development

Table 126. Shijiazhuang Pharma Group Company Details

Table 127. Shijiazhuang Pharma Group Business Overview

Table 128. Shijiazhuang Pharma Group Generic Injection Product

Table 129. Shijiazhuang Pharma Group Revenue in Generic Injection Business (2020-2025) & (US$ Million)

Table 130. Shijiazhuang Pharma Group Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Generic Injection Picture

Figure 2. Global Generic Injection Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Generic Injection Market Share by Type: 2024 VS 2031

Figure 4. Liquid Injection Features

Figure 5. Powder for Injection Features

Figure 6. Global Generic Injection Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Generic Injection Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Generic Injection Report Years Considered

Figure 12. Global Generic Injection Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Generic Injection Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Generic Injection Market Share by Region: 2024 VS 2031

Figure 15. Global Generic Injection Market Share by Players in 2024

Figure 16. Global Top Generic Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injection as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Generic Injection Revenue in 2024

Figure 18. North America Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Generic Injection Market Share by Country (2020-2031)

Figure 20. United States Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Generic Injection Market Share by Country (2020-2031)

Figure 24. Germany Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Generic Injection Market Share by Region (2020-2031)

Figure 32. China Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Generic Injection Market Share by Country (2020-2031)

Figure 40. Mexico Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Generic Injection Market Share by Country (2020-2031)

Figure 44. Turkey Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Generic Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Sanofi Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 48. Fresenius Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 49. Viatris Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 52. Hikma Pharmaceuticals Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 54. Amneal Pharmaceuticals Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 55. Gland Pharma Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 56. Allergan Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 57. Kelun Pharmaceutical Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 58. Jiangsu HRS Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 59. Qilu Pharmaceutical Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 60. Chiatai Tianqing Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 61. Hainan Poly Pharm Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 62. Yangzijiang Pharmaceutical Industry Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 63. Shijiazhuang Pharma Group Revenue Growth Rate in Generic Injection Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Super Generics Market

Global Generic Anti cancer Injectables Market Research Report 2025

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Generic Injectable Drugs Market Research Report 2024

Global Generic API Market Research Report 2025

Global Eye Injection Market Research Report 2024

Injection and Infusion Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Etamsylate Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Aesthetic Injections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tocilizumab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Aprepitant Injection Market Research Report 2025

Astragalus Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Arthritis Pain Injection Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Generic Injectable Drugs Market Research Report 2024

Generic and Biosimilar Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ceftriaxone Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Contraceptive Injectable Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fulvestrant Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions